Action Point Financial Planning’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
Other funds holding NAMS
DFO
Action Point Financial Planning's NAMS Position: Q3 2026 in Review
Action Point Financial Planning sold out of NewAmsterdam Pharma (NAMS) in Q3 2026, closing a stake of 13 shares — an estimated $441 sold.
Action Point Financial Planning first reported a position in NAMS in Q2 2026 and held it in 1 quarter. The position peaked at $441 in Q2 2026. 183 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.
- Action Point Financial Planning reported no remaining NewAmsterdam Pharma position as of Q3 2026 after selling out during the quarter.
- Action Point Financial Planning sold 13 NewAmsterdam Pharma shares in Q3 2026, an estimated $441.
- Action Point Financial Planning first reported a position in NewAmsterdam Pharma in Q2 2026 and held it in 1 quarter.
- Action Point Financial Planning's NewAmsterdam Pharma position peaked at $441 in Q2 2026.
- 183 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.
Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.